Cargando…

AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle

BACKGROUND: Insulin resistance triggered by excess fat is a key pathogenic factor that promotes type 2 diabetes. Understanding molecular mechanisms of insulin resistance may lead to the identification of a novel therapeutic target for type 2 diabetes. AMPD1, an isoform of AMP deaminase (AMPD), is su...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandelilin, Andreas AK, Hirase, Tetsuaki, Hudoyo, Athanasius W, Cheng, Jidong, Toyama, Keiko, Morisaki, Hiroko, Morisaki, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520000/
https://www.ncbi.nlm.nih.gov/pubmed/25887856
http://dx.doi.org/10.1186/s12902-015-0010-9
_version_ 1782383593967845376
author Tandelilin, Andreas AK
Hirase, Tetsuaki
Hudoyo, Athanasius W
Cheng, Jidong
Toyama, Keiko
Morisaki, Hiroko
Morisaki, Takayuki
author_facet Tandelilin, Andreas AK
Hirase, Tetsuaki
Hudoyo, Athanasius W
Cheng, Jidong
Toyama, Keiko
Morisaki, Hiroko
Morisaki, Takayuki
author_sort Tandelilin, Andreas AK
collection PubMed
description BACKGROUND: Insulin resistance triggered by excess fat is a key pathogenic factor that promotes type 2 diabetes. Understanding molecular mechanisms of insulin resistance may lead to the identification of a novel therapeutic target for type 2 diabetes. AMPD1, an isoform of AMP deaminase (AMPD), is suggested to play roles in the regulation of glucose metabolism through controlling AMP-activated protein kinase (AMPK) activation. We reported that the diet-induced insulin resistance was improved in AMPD1-deficient mice compared to wild type mice. To further delineate this observation, we studied changes of insulin signaling in skeletal muscle of wild type (WT) and AMPD1-deficient mice. METHODS: Phosphorylation levels of kinases and expression levels of mTOR components were quantified by immunoblotting using protein extracts from tissues. The interaction between mTOR and Raptor was determined by immunoblotting of mTOR immunoprecipitates with anti-Raptor antibody. Gene expression was studied by quantitative PCR using RNA extracted from tissues. RESULTS: Phosphorylation levels of AMPK, Akt and p70 S6 kinase in skeletal muscle were higher in AMPD1-deficient mice compared to WT mice after high fat diet challenge, while they did not show such difference in normal chow diet. Also, no significant changes in phosphorylation levels of AMPK, Akt or p70 S6 kinase were observed in liver and white adipose tissue between WT and AMPD1-deficient mice. The expression levels of mTOR, Raptor and Rictor tended to be increased by AMPD1 deficiency compared to WT after high fat diet challenge. AMPD1 deficiency increased Raptor-bound mTOR in skeletal muscle compared to WT after high fat diet challenge. Gene expression of peroxisome proliferator-activated receptor-γ coactivator 1α and β, downstream targets of p70 S6 kinase, in skeletal muscles was not changed significantly by AMPD1 deficiency compared to the wild type after high fat diet challenge. CONCLUSION: These data suggest that AMPD1 deficiency activates AMPK/Akt/mTORC1/p70 S6 kinase axis in skeletal muscle after high fat diet challenge, but not in normal chow diet. These changes may contribute to improve insulin resistance.
format Online
Article
Text
id pubmed-4520000
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45200002015-07-31 AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle Tandelilin, Andreas AK Hirase, Tetsuaki Hudoyo, Athanasius W Cheng, Jidong Toyama, Keiko Morisaki, Hiroko Morisaki, Takayuki BMC Endocr Disord Research Article BACKGROUND: Insulin resistance triggered by excess fat is a key pathogenic factor that promotes type 2 diabetes. Understanding molecular mechanisms of insulin resistance may lead to the identification of a novel therapeutic target for type 2 diabetes. AMPD1, an isoform of AMP deaminase (AMPD), is suggested to play roles in the regulation of glucose metabolism through controlling AMP-activated protein kinase (AMPK) activation. We reported that the diet-induced insulin resistance was improved in AMPD1-deficient mice compared to wild type mice. To further delineate this observation, we studied changes of insulin signaling in skeletal muscle of wild type (WT) and AMPD1-deficient mice. METHODS: Phosphorylation levels of kinases and expression levels of mTOR components were quantified by immunoblotting using protein extracts from tissues. The interaction between mTOR and Raptor was determined by immunoblotting of mTOR immunoprecipitates with anti-Raptor antibody. Gene expression was studied by quantitative PCR using RNA extracted from tissues. RESULTS: Phosphorylation levels of AMPK, Akt and p70 S6 kinase in skeletal muscle were higher in AMPD1-deficient mice compared to WT mice after high fat diet challenge, while they did not show such difference in normal chow diet. Also, no significant changes in phosphorylation levels of AMPK, Akt or p70 S6 kinase were observed in liver and white adipose tissue between WT and AMPD1-deficient mice. The expression levels of mTOR, Raptor and Rictor tended to be increased by AMPD1 deficiency compared to WT after high fat diet challenge. AMPD1 deficiency increased Raptor-bound mTOR in skeletal muscle compared to WT after high fat diet challenge. Gene expression of peroxisome proliferator-activated receptor-γ coactivator 1α and β, downstream targets of p70 S6 kinase, in skeletal muscles was not changed significantly by AMPD1 deficiency compared to the wild type after high fat diet challenge. CONCLUSION: These data suggest that AMPD1 deficiency activates AMPK/Akt/mTORC1/p70 S6 kinase axis in skeletal muscle after high fat diet challenge, but not in normal chow diet. These changes may contribute to improve insulin resistance. BioMed Central 2015-03-27 /pmc/articles/PMC4520000/ /pubmed/25887856 http://dx.doi.org/10.1186/s12902-015-0010-9 Text en © licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tandelilin, Andreas AK
Hirase, Tetsuaki
Hudoyo, Athanasius W
Cheng, Jidong
Toyama, Keiko
Morisaki, Hiroko
Morisaki, Takayuki
AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
title AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
title_full AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
title_fullStr AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
title_full_unstemmed AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
title_short AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
title_sort ampd1 regulates mtorc1-p70 s6 kinase axis in the control of insulin sensitivity in skeletal muscle
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520000/
https://www.ncbi.nlm.nih.gov/pubmed/25887856
http://dx.doi.org/10.1186/s12902-015-0010-9
work_keys_str_mv AT tandelilinandreasak ampd1regulatesmtorc1p70s6kinaseaxisinthecontrolofinsulinsensitivityinskeletalmuscle
AT hirasetetsuaki ampd1regulatesmtorc1p70s6kinaseaxisinthecontrolofinsulinsensitivityinskeletalmuscle
AT hudoyoathanasiusw ampd1regulatesmtorc1p70s6kinaseaxisinthecontrolofinsulinsensitivityinskeletalmuscle
AT chengjidong ampd1regulatesmtorc1p70s6kinaseaxisinthecontrolofinsulinsensitivityinskeletalmuscle
AT toyamakeiko ampd1regulatesmtorc1p70s6kinaseaxisinthecontrolofinsulinsensitivityinskeletalmuscle
AT morisakihiroko ampd1regulatesmtorc1p70s6kinaseaxisinthecontrolofinsulinsensitivityinskeletalmuscle
AT morisakitakayuki ampd1regulatesmtorc1p70s6kinaseaxisinthecontrolofinsulinsensitivityinskeletalmuscle